3m Company (MMM) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
3m Company  (CHX: MMM)


3m's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 3m's ROI in the third quarter of 2026?
3m Company achieved a return on average invested assets (ROI) of 13.34 % in its third quarter of 2026, which is below 3m's average return on investment, which stands at 15.66%.

ROI has improved compared to 11.24% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 44 other companies had a higher return on investment. While the total ranking for ROI remained the same, compared to the second quarter of 2026 at no. 821.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -9.02 % -8.69 % -2.34 % -8.24 % -13.16 %
Y / Y Net Income Change TTM 3.75 % -23.77 % -13.24 % 55.04 % 148.26 %
Investment (TTM) in Millions 27,658 23,545 26,452 28,601 28,546
Return On Investment (TTM) 13.34 % 11.24 % 9.87 % 11.14 % 11.7 %
MMM's Overall Ranking # 821 # 821 # 657 # 547 # 493
Seq. Investment Change TTM -0.83 % -5.55 % -3.15 % 0.29 % -0.47 %
Seq. Net Income Change TTM 17.66 % 7.61 % -14.19 % -4.51 % -13.54 %
Net Income (TTM) in Millions 3,544 3,012 2,799 3,262 3,416

MMM Company Profile >> Back to MMM Roi Comparisons >> See Annual MMM Return On Investment



Return On Investment MMM's Ranking
Within: No.
Industry # 11
Sector # 45
Overall # 821

Return On Investment Statistics
High Average Low
28.8 %
15.66 %
-20.29 %
(June 30, 2007)   (Sep 30 2023)







Financial Statements
3m's III. Quarter Investments $ 27,658 Millions MMM's Balance sheet
3m's III. Quarter Income $ 1,373 Millions Quarterly MMM's Income Statement
MMM's Income by Division See MMM's Income by Division


MMM Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 28,183 28,259 34,810 36,400 37,517
Y / Y Investment Growth -0.27 % -18.82 % -4.37 % -2.98 % -3.43 %
Net Income in Millions 3,262 4,188 -6,979 5,791 5,929
Y / Y Net Income Growth -22.11 % - - -2.33 % 10.04 %
Annual Return On Investment 11.57 % 14.82 % -20.05 % 15.91 % 15.8 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 11.57 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MMM's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MMM's Competitors
Subscribers only: Roi for 3m's Suppliers
Subscribers only: Return On Investment for MMM's Customers

Other Ratios
MMM's Roa MMM's Inventory Turnover Ratio MMM's Growth Rates MMM's Dividend Statistics
MMM's Profitability Ratios MMM's Asset Turnover Ratio MMM's Dividend Growth
MMM's Roe MMM's Valuation Ratios MMM's Financial Strength Ratios MMM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Rallybio Corporation  36.04 %
Eli Lilly And Company  32.00 %
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %

Date modified: 2026-10-21T05:02:19+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.